183 related articles for article (PubMed ID: 15136515)
1. Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench.
Shimada K; Miyauchi K; Daida H
Circulation; 2004 May; 109(18):e213-4; author reply e213-4. PubMed ID: 15136515
[No Abstract] [Full Text] [Related]
2. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
Wamhoff BR; Dixon JL; Sturek M
J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin for acute coronary syndromes.
Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR
JAMA; 2001 Aug; 286(5):533-5. PubMed ID: 11476650
[No Abstract] [Full Text] [Related]
4. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Auer J; Weber T; Eber B
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309747
[No Abstract] [Full Text] [Related]
5. Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
Ghali JK
Am J Cardiol; 1998 Sep; 82(5):703. PubMed ID: 9732912
[No Abstract] [Full Text] [Related]
6. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
Clearfield M
Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
[No Abstract] [Full Text] [Related]
7. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
Bloom JM
N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466
[No Abstract] [Full Text] [Related]
8. HMG-CoA reductase inhibitors and renal function.
Campese VM; Park J
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1100-3. PubMed ID: 17942762
[No Abstract] [Full Text] [Related]
9. Colestimide co-administered with atorvastatin attenuates the progression of vascular calcification in haemodialysis patients.
Nitta K; Akiba T; Nihei H
Nephrol Dial Transplant; 2004 Aug; 19(8):2156. PubMed ID: 15252184
[No Abstract] [Full Text] [Related]
10. [Atorvastatin in treatment of patients with coronary heart disease and dislipidemiya and high general risk: efficiency and safety estimation. Design and main results of ATLANTIKA].
Mareev VIu; Belenkov IuN; Oganov RG; Barbik-Zhagar B
Kardiologiia; 2008; 48(11):4-13. PubMed ID: 19076074
[No Abstract] [Full Text] [Related]
11. Atorvastatin for acute coronary syndromes.
Wierzbicki AS; Mikhaildis DP; Reynolds TR
JAMA; 2001 Aug; 286(5):532-3; author reply 533-5. PubMed ID: 11476649
[No Abstract] [Full Text] [Related]
12. C-reactive protein levels and outcomes after statin therapy.
Clearfield M
Curr Atheroscler Rep; 2006 Jan; 8(1):8-9. PubMed ID: 16455006
[No Abstract] [Full Text] [Related]
13. Lipid-lowering therapy in acute coronary syndromes.
Sacks FM
JAMA; 2001 Apr; 285(13):1758-60. PubMed ID: 11277832
[No Abstract] [Full Text] [Related]
14. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
15. [First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].
Einecke D
MMW Fortschr Med; 2003 Dec; 145(51-52):38. PubMed ID: 14974329
[No Abstract] [Full Text] [Related]
16. [High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].
Einecke D
MMW Fortschr Med; 2006 Jun; 148(24):4-5. PubMed ID: 16850796
[No Abstract] [Full Text] [Related]
17. [Atorvastatin (Lipitor)].
Carpentier Y; Ducobu J; Sternon J
Rev Med Brux; 1999 Oct; 20(5):427-33. PubMed ID: 10582478
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
Liguori E; Sarcinella R
Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861
[No Abstract] [Full Text] [Related]
19. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
[No Abstract] [Full Text] [Related]
20. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
